Detection of Alternative Lengthening of Telomeres via Chromogenic In Situ Hybridization for the Prognostication of PanNETs and Other Neoplasms
Modern Pathology · 2025
DOI: 10.1016/j.modpat.2024.100651 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Modern Pathology, 2025. Verfasst von Christopher M Heaphy und 43 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Boston University School of Medicine, Boston, Massachusetts. Electronic address: heaphyc@bu.edu. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Neuroendocrine Tumors, In Situ Hybridization, Telomere Homeostasis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Molecular studies have shown alternative lengthening to telomeres (ALT) to be an important prognostic biomarker of shorter relapse-free survival (RFS) for patients with pancreatic neuroendocrine tumors (PanNETs) and other neoplasms. However, the preferred method of detecting ALT in tissue is by fluorescence in situ hybridization (FISH), which has several clinical limitations. These issues necessitate the creation of a chromogenic ALT assay that can be easily implemented into routine practice. A chromogenic in situ hybridization (CISH) assay was developed using genetically modified osteosarcoma cell lines, 20 normal pancreata, 20 ALT-positive PanNETs, and 20 ALT-negative PanNETs. Thereafter, it was validated on a multiinstitutional cohort of 360 surgically resected PanNETs and correlated with multiple clinicopathologic features, RFS, and FISH results. Separately, 109 leiomyosarcomas (LMS) were evaluated by both CISH and FISH, and, similarly, the prognostic significance of ALT status was assessed. Upon optimization, ALT-CISH was identified in 112 of 360 (31%) primary PanNETs and was 100% concordant with FISH testing. ALT correlated with several adverse prognostic findings and distant metastasis (all P < .004). The 5-year RFS for patients with ALT-positive PanNETs was 35% as compared with 94% for ALT-negative PanNETs. By multivariate analysis, ALT was an independent prognostic factor for shorter RFS. Similarly, ALT was associated with shorter RFS in patients with LMS and, analogous to PanNETs, a negative, independent prognostic factor. ALT-CISH was developed and validated in not only PanNETs but also sarcomas, specifically LMS. CISH testing has multiple advantages over FISH that facilitate its widespread clinical use in the detection of ALT and prognostication of patients with diverse neoplasms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Boston University School of Medicine, Boston, Massachusetts. Electronic address: heaphyc@bu.edu.
- Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
- Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, Pennsylvania.
- Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri.
- Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, Maryland.
- Department of Medicine, Boston University School of Medicine, Boston, Massachusetts.
Förderung
- NCI NIH HHS
Zitieren
APA
Heaphy, C. M., Patel, S., Smith, K., Wondisford, A. R., Lynskey, M. L., O'Sullivan, R. J., Fuhrer, K., Han, X., Seethala, R. R., Liu, T. C., Cao, D., Ertunc, O., Zheng, Q., Stojanova, M., Zureikat, A. H., Paniccia, A., Lee, K., Ongchin, M. C., Pingpank, J. F., …, & Singhi, A. D. (2025). Detection of Alternative Lengthening of Telomeres via Chromogenic In Situ Hybridization for the Prognostication of PanNETs and Other Neoplasms. Modern Pathology. https://doi.org/10.1016/j.modpat.2024.100651
Vancouver
Heaphy CM, Patel S, Smith K, Wondisford AR, Lynskey ML, O'Sullivan RJ, et al. Detection of Alternative Lengthening of Telomeres via Chromogenic In Situ Hybridization for the Prognostication of PanNETs and Other Neoplasms. Modern Pathology. 2025. doi:10.1016/j.modpat.2024.100651
BibTeX
@article{Heaphy2025,
author = {Heaphy, Christopher M and Patel, Simmi and Smith, Katelyn and Wondisford, Anne R and Lynskey, Michelle L and O'Sullivan, Roderick J and Fuhrer, Kimberly and Han, Xiaoli and Seethala, Raja R and Liu, Ta-Chiang and Cao, Dengfeng and Ertunc, Onur and Zheng, Qizhi and Stojanova, Marija and Zureikat, Amer H and Paniccia, Alessandro and Lee, Kenneth and Ongchin, Melanie C and Pingpank, James F and Zeh, Herbert J and Hogg, Melissa E and Geller, David and Marsh, James Wallis and Brand, Randall E and Chennat, Jennifer S and Das, Rohit and Fasanella, Kenneth E and Gabbert, Charles and Khalid, Asif and McGrath, Kevin and Lennon, Anne Marie and Sarkaria, Savreet and Singh, Harkirat and Slivka, Adam and Hsu, Dennis and Zhang, Janie Y and Nacev, Benjamin A and Nikiforova, Marina N and Wald, Abigail I and Vaddi, Neel and De Marzo, Angelo M and Singhi, Anju H and Bell, Phoenix D and Singhi, Aatur D},
title = {Detection of Alternative Lengthening of Telomeres via Chromogenic In Situ Hybridization for the Prognostication of PanNETs and Other Neoplasms},
journal = {Modern Pathology},
year = {2025},
doi = {10.1016/j.modpat.2024.100651}
}
EUVIMED